Lysophosphatidic acid and lovastatin might protect kidney in renal I/R injury by downregulating MCP-1 in rat

Renal Failure

Volumn 33, Issue 8, 2011, Pages 805-810

  Gao, Jin ^a   Zhang, Duo ^b   Yang, Xiaoqing ^a   Zhang, Yayu ^a   Li, Peng ^a   Su, Xiulan ^a  

^a INNER MONGOLIA MEDICAL COLLEGE   (China)

^b Chinese and Mongolia Medicine Hospital   (China)

Author keywords

Chemotactic factor; Lovastatin; Lysophosphatidic acid; Monocyte chemotactic protein 1; Renal ischemia reperfusion injury

Indexed keywords

CREATININE; H 10970092; LYSOPHOSPHATIDIC ACID; MEVINOLIN; MONOCYTE CHEMOTACTIC PROTEIN 1; UNCLASSIFIED DRUG; UREA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHEMOPROPHYLAXIS; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DOWN REGULATION; DRUG MECHANISM; GLOMERULUS; HISTOPATHOLOGY; KIDNEY FUNCTION; KIDNEY FUNCTION TEST; KIDNEY INJURY; KIDNEY ISCHEMIA; KIDNEY PARENCHYMA; KIDNEY TUBULE; MALE; NONHUMAN; PALLER SCORE; PRIORITY JOURNAL; RAT; REPERFUSION INJURY; SCORING SYSTEM; TISSUE LEVEL; UREA NITROGEN BLOOD LEVEL;

ANIMALS; CHEMOKINE CCL2; DOWN-REGULATION; KIDNEY; LOVASTATIN; LYSOPHOSPHOLIPIDS; MALE; RATS; RATS, WISTAR; REPERFUSION INJURY;

EID: 80052251799     PISSN: 0886022X     EISSN: 15256049     Source Type: Journal    
DOI: 10.3109/0886022X.2011.601829     Document Type: Article

References (26)

1. Agrawal M, Swartz R. Acute renal failure. Am Fam Physician. 2000;61:2077-2088. (Pubitemid 30225614)
2. Chao IF, Ransohoff RM. The many roles of chemokines and chemokine receptors in inflammation. N Engl J Med. 2006;354:610-621. (Pubitemid 43209108)
3. Frangogiannis NG. Chemokines in ischemia and reperfusion. Thromb Hemost. 2007;97:738-747. (Pubitemid 46779959)
4. JassemW, Fuggle SV, Rela M, Koo DD, Heaton ND. The role of mitochondria in ischemia/reperfusion injury. Transplantation. 2002;73:493-499. (Pubitemid 34193605)
5. Daemen MA, de Vries B, Buurman WA. Apoptosis and inflammation in renal reperfusion injury. Transplantation. 2002;73:1693-1700. (Pubitemid 34655241)
6. Duque N, Gomez-Guerrero C, Egido J. Interaction of IgA with Fc alpha receptors of human mesangial cells activates transcription factor nuclear factor-kappa B and induces expression and synthesis of monocyte chemoattractant protein-1, IL-8, and IFN-inducible protein 10. J Immunol. 1997;159: 3474-3482. (Pubitemid 127482106)
7. Kakio T, Matsumori A, Ono K, Ito H, Matsushima K, Sasayama S. Roles and relationship of macrophages and monocyte chemotactic and activating factor/monocyte chemoattractant protein-1 in the ischemic and reperfused rat heart. Lab Invest. 2000;80:1127-1136. (Pubitemid 30483232)
8. Stroo I, Stokman G, Teske GJ, et al. Chemokine expression in renal ischemia/reperfusion injury is most profound during the reparative phase. Int Immunol. 2010;22:433-442.
9. Furuichi K, Wada T, Iwata Y, et al. CCR2 signaling contributes to ischemia-reperfusion injury in kidney. J Am Soc Nephrol. 2003;14:2503-2515. (Pubitemid 37169336)
10. Furuichi K, Wada T, Iwata Y, et al. Gene therapy expressing amino-terminal truncated monocyte chemoattractant protein-1 prevents renal ischemia-reperfusion injury. J Am Soc Nephrol. 2003;14:1066-1071. (Pubitemid 36359289)
11. de Vries B, Matthijsen RA, van Bijnen AA, Wolfs TG, Buurman WA. Lysophosphatidic acid prevents renal ischemiareperfusion injury by inhibition of apoptosis and complement activation. Am J Pathol. 2003;163:47-56. (Pubitemid 36759590)
12. Thurman JM, Lenderink AM, Royer PA, et al. C3a is required for the production of CXC chemokines by tubular epithelial cells after renal ishemia/reperfusion. J Immunol. 2007;178:1819-1828. (Pubitemid 46154654)
13. Yuzbasioglu MF, Aykas A, Kurutas EB, Sahinkanat T. Protective effects of propofol against ischemia/reperfusion injury in rat kidneys. Ren Fail. 2010;32:578-583.
14. Fouad AA, Qureshi HA, Al-Sultan Al, Yacoubi MT, Al-Melhim WN. Nephroprotective effect of telmisartan in rats with ischemia/reperfusion renal injury. Pharmacology. 2010;85: 158-167.
15. Horvath G, Racz B, Reglodi D, et al. Effects of PACAP on mitochondrial apoptotic pathways and cytokine expression in rats subjected to renal ischemia/reperfusion. J Mol Neurosci. 2010;42:411-418.
16. Semedo P,Wang PM, Andreucci TH, et al. Mesenchymal stem cells ameliorate tissue damages triggered by renal ischemia and reperfusion injury. Transplant Proc. 2007;39:421-423. (Pubitemid 46386253)
17. Zhuo W, Liao L, Xu T, Wu W, Yang S, Tan J. Mesenchymal stem cells ameliorate ischemia-reperfusion-induced renal dysfunction by improving the antioxidant/oxidant balance in the ischemic kidney. Urol Int. 2010;82(6):191-196; doi:10.1159/000319366.
18. Li B, Cohen A, Hudson TE, Motlagh D, Amrani DL, Duffield JS. Mobilized human hematopoietic stem/progenitor cells promote kidney repair after ischemia/reperfusion injury. Circulation. 2010;121:2211-2220.
19. Pisani A, Uccello F, Cesaro A, et al. Effects of atorvastatin on ischemic acute renal failure in aging rats. G Ital Nefrol. 2002;19:534-539.
20. Zoja C, Corna D, Rottoli D, et al. Effect of combining ACE inhibitor and statin in severe experimental nephropathy. Kindey Int. 2002;61:1635-1645. (Pubitemid 34437917)
21. Lu JX, Ping JG, Yan CY. Establish of rat model of renal cold ischemia-reperfusion injury. Chin J Hemorheol. 2005;15: 45-47.
22. Paller MS, Hoidal JR, Ferris TF. Oxygen free radicals in ischemic acute renal failure in the rat. J Clin Invest. 1984;74:1156-1164. (Pubitemid 15206810)
23. Contos JJ, Ishii I, Chun J. Lysophosphatidic acid receptors. Mol Pharmacol. 2000;58:1188-1196.
24. Balazs L, Okolicany J, Ferrebee M, Tolley B, Tigyi G. Topical application of the phospholipid growth factor lysophosphatidic acid promotes wound healing in vivo. Am J Physiol Regul Integr Comp Physiol. 2001;280:R466-R472.
25. Inoue CN. LPA as a determinant of mesangial growth and apoptosis. Semin Nephrol. 2002;22:415-422. (Pubitemid 35024518)
26. Chen X, Yang XY, Wang ND, et al. Serum lysophosphatidic acid concentrations measured by dot immunogold filtration assay in patients with acute myocardial infarction. Scand J Clin Lab Invest. 2003;63:497-503. (Pubitemid 38121716)